BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
Pharmaceutical Technology
JUNE 19, 2025
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory in space in 2026. Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Image credit: Rini. com/ Shutterstock.
Let's personalize your content